Inhalant allergies are much more common than contact allergies. Rather than developing itchy eyes and stuffy noses, though, ...

AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed ...

People with severe peanut allergies produce large amounts of immunoglobulin E (IgE) antibodies when exposed to peanut proteins, including two called Ara h 1 and 2. This leads to an inflammation ...

Final stage of the OUtMATCH trial tracks outcomes for oral immunotherapy versus omalizumab ...

People with allergic fungal rhinosinusitis taking Dupixent (dupilumab) saw significant improvement in congestion and sinus ...

If you’re bothered by allergies every spring, you may pop a Benadryl or Claritin most mornings to make the days tolerable. Two-thirds of Americans report spring allergies, and about 4 in 10 say they ...

Researchers in England have found that roughly 80 percent of children with peanut allergies who participated in an experimental treatment were able to build resistance to the allergy and can now ...

The peanut allergy is one of the most prevalent, feared, contested and ridiculed conditions in America today. For children (and adults) who are allergic to peanuts, the consequences may be severe — ...

One of the big mysteries in food allergy is why two people with similar levels of peanut specific antibodies can react so ...

Please provide your email address to receive an email when new articles are posted on . Patients who used omalizumab could tolerate small amounts of allergen proteins. Omalizumab does not modulate ...

Please provide your email address to receive an email when new articles are posted on . Researchers, entrepreneurs, clinicians and other stakeholders from multiple specialties are welcome. Attendees ...

The new report provides a comprehensive assessment of the growing public health impact of food allergy in the United States ...